Sage Therapeutics, Inc. (SAGE) Social Stream
SAGE THERAPEUTICS INC (SAGE) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering SAGE.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-12-01 | 20 | $105 | $48 | $73.368 | $44.59 | 64.54% |
| 2021-12-20 | 19 | $105 | $48 | $72.842 | $44.59 | 63.36% |
| 2022-01-12 | 19 | $105 | $48 | $73.157 | $44.59 | 64.07% |
| 2022-01-26 | 17 | $105 | $48 | $73.157 | $44.59 | 64.07% |
| 2022-02-16 | 17 | $105 | $48 | $72.315 | $44.59 | 62.18% |
| 2022-02-25 | 18 | $105 | $48 | $71.736 | $44.59 | 60.88% |
| 2022-02-28 | 17 | $105 | $48 | $70.055 | $44.59 | 57.11% |
| 2022-03-21 | 17 | $105 | $40 | $68.722 | $44.59 | 54.12% |
| 2022-04-01 | 18 | $105 | $37 | $67.052 | $44.59 | 50.37% |
| 2022-05-03 | 18 | $105 | $37 | $67.21 | $44.59 | 50.73% |
| 2022-05-04 | 18 | $105 | $37 | $65.7 | $44.59 | 47.34% |
| 2022-05-06 | 18 | $105 | $37 | $64.631 | $44.59 | 44.95% |
| 2022-05-10 | 18 | $105 | $37 | $64.421 | $44.59 | 44.47% |
| 2022-05-24 | 19 | $105 | $37 | $64.85 | $44.59 | 45.44% |
| 2022-06-01 | 19 | $105 | $37 | $65 | $44.59 | 45.77% |
| 2022-06-13 | 19 | $105 | $36 | $64.2 | $44.59 | 43.98% |
| 2022-07-21 | 18 | $105 | $36 | $61 | $44.59 | 36.8% |
| 2022-08-03 | 18 | $105 | $36 | $57.941 | $44.59 | 29.94% |
| 2022-08-04 | 18 | $105 | $36 | $59.611 | $44.59 | 33.69% |
| 2022-09-19 | 18 | $105 | $36 | $59.5 | $44.59 | 33.44% |
| 2022-10-17 | 16 | $105 | $36 | $59.5 | $44.59 | 33.44% |
| 2022-11-01 | 17 | $105 | $36 | $58.526 | $44.59 | 31.25% |
| 2022-11-08 | 17 | $105 | $36 | $59.111 | $44.59 | 32.57% |
| 2022-11-11 | 18 | $105 | $36 | $57 | $44.59 | 27.83% |
| 2022-11-21 | 19 | $105 | $36 | $56.85 | $44.59 | 27.49% |
| 2022-12-07 | 20 | $105 | $36 | $55 | $44.59 | 23.35% |
| 2023-01-25 | 20 | $105 | $36 | $55.3 | $44.59 | 24.02% |
The Trend in the Analyst Price Target
Over the past 35 weeks, SAGE's average price target has gone down $9.55.
SAGE reports an average of 71.82% for its upside potential over the past 49 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-06-01 | 19 | 105 | 36 | 64.20 | 34.24 | 87.5% |
| 2022-07-21 | 18 | 105 | 36 | 61.00 | 35.58 | 71.44% |
| 2022-08-10 | 18 | 105 | 36 | 59.50 | 42.84 | 38.89% |
| 2022-10-17 | 17 | 105 | 36 | 59.50 | 38.07 | 56.29% |
| 2022-11-21 | 19 | 105 | 36 | 56.85 | 35.05 | 62.2% |
SAGE Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.15 | 8 | 1 | 11 | 0 | 0 | 20 |
The Trend in the Broker Recommendations
Over the past 13 months, SAGE's average broker recommendation rating improved by 0.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for SAGE as an investment opportunity.
- SAGE THERAPEUTICS INC's number of analysts covering the stock is higher than 3471.23% of all US stocks.
- In terms of how SAGE THERAPEUTICS INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -3223.02% of that group.
- In terms of how SAGE THERAPEUTICS INC fares relative to Pharmaceutical Products stocks, note that its average analyst price target is higher than 2910.06% of that group.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, SAGE THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 1083.32% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to SAGE THERAPEUTICS INC are RCKT, FGEN, and XENE.
View All Top Stocks by Price Target
Make investment decisions regarding SAGE using the data that counts. Try POWR Ratings for free.